Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test
Abstract
Plasma levels of 3-methoxy-4-hydroxyphenylglycol (MHPG) were measured in 51 depressed patients and 43 normal control subjects. There were significantly higher plasma MHPG levels in the combined patient group with current or past melancholia (N = 28) than in nonmelancholic (N = 12) or dysthymic (N = 11) patients, in unipolar melancholic (N = 16) versus bipolar melancholic (N = 4) patients, and in patients with a major depressive episode who failed to suppress cortisol after the dexamethasone suppression test (N = 24) versus patients with normal suppression (N = 16). Anxiety symptoms correlated significantly with plasma MHPG levels. These results substantiate previous evidence that dysregulation of the hypothalamic-pituitary-adrenal axis and sympathetic nervous system occur together in a subgroup of depressed patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).